Search Results - "Gluckman, M I"

Animal pharmacology of Wy-16,225, a new analgesic agent by Malis, J L, Rosenthale, M E, Gluckman, M I

“…The analgesic potency of Wy-16,225 in rodents and primates is greater than morphine while antagonist potency is slightly less than that of nalorphine. The…”
Get more information

Pharmacology of lorazepam by Gluckman, M I, Stein, L

“…Lorazepam reduced conflict behavior in rats and monkeys, inhibited pentylenetetrazol- and electroshock-induced convulsions, suppressed footshock-induced…”
Get full text

Immunopharmacologic properties of WY-16, 922, a new orally effective antiallergic agent by Rosenthale, M E, Begany, A J, Dervinis, A, Sellstedt, J, Guinosso, C, Gluckman, M I

“…In a series of tests designed to illustrate immune reactions similar to those obtained in atopic disease, Wy-16,922 effectively inhibited reaginic-mediated…”
Get more information

Immunopharmacologic properties of WY-16,922, a new orally effective antiallergic agent by Rosenthale, M E, Begany, A J, Dervinis, A, Sellstedt, J, Guinosso, C, Gluckman, M I

“…In a series of tests designed to illustrate immune reactions similar to those obtained in atopic disease, Wy-16,922 effectively inhibited reaginic-mediated…”
Get more information

Mechanism of the inhibitory effects of cardiac glycosides on lipolysis by Yu, D H, Triester, S, Gluckman, M I

Get more information

Mechanism of antilipolytic effects of cardiac glycosides by Yu, D H, Triester, S, Gluckman, M I

Get more information

The effect of dipyridamole on the metabolism of cardiac muscle by Yu, D H, Gluckman, M I

Get more information

Pharmacology of 7-chloro-5-(o-chlorophenyl)-1,3-dihydro-3-hydroxy-2H-1,4-benzodiazepin-2-one (lorazepam; Wy 4036) by Gluckman, M I

Get more information

1,4-BENZODIAZEPINES by CHILDRESS, S J, GLUCKMAN, M I

Get more information

Comparative actions of some neuromuscular blocking agents on red and white muscle in the dog by GLUCKMAN, M I

Get more information

In vitro interactions of the new anorexic agent WY-5244 with cardiac and vascular tissue and with adrenergic mechanisms by Baum, T, Gluckman, M I

Get more information

Anti-inflammatory properties of 4,5-diphenyl-2-oxazolepropionic acid (oxaprozin) by Rosenthale, M E, Begany, A J, Dervinis, A, Malis, J L, Shriver, D A, Datko, S L, Gluckman, M I

Get full text

On the mechanism of the pharmacologic activity of meclofenamate sodium by McLean, J R, Gluckman, M I

“…N-(2,6-Dichloro-m-tolyl)anthranilic acid, sodium salt (meclofenamate sodium, Meclomen), the sodium salt of meclofenamic acid, has anti-inflammatory activity…”
Get more information

General pharmacologic actions of the antihypertensive agent 2,6-dichlorobenzylidene aminoguanidine acetate (WY-8678) by Baum, T, Shropshire, A T, Rowles, G, Van Pelt, R, Fernandez, S P, Eckfeld, D K, Gluckman, M I

Get more information

Immunopharmacologic activity of 1-aminocyclopentane-1-carboxylic acid by Rosenthale, M E, Gluckman, M I

Get full text

A new anorexic agent, WY-5244: cardiovascular actions and influence on sympathomimetic amines by Baum, T, Gluckman, M I

Get more information

2,6-Dichlorobenzylidene amino guanidine acetate (Wy-8678). A new hypotensive agent by Baum, T, Eckfeld, D K, Metz, N, Dinish, J L, Rowles, G, Van Pelt, R, Shropshire, A T, Fernandez, S P, Gluckman, M I, Bruce, W F

Get full text

The actions of barbiturates on the contractions of voluntary muscle by KRAATZ, C P, GLUCKMAN, M I

Get more information

The effects of thiopental and pentobarbital on voluntary muscle by KRAATZ, C P, GLUCKMAN, M I, SHIELDS, H L

Get more information

Isoxicam by Downie, W W, Gluckman, M I, Ziehmer, B A, Boyle, J A

Get more information